相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects
Justin A. Green et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study
Alejandro Llanos-Cuentas et al.
LANCET (2014)
Mefloquine safety and tolerability in pregnancy: a systematic literature review
Raquel Gonzalez et al.
MALARIA JOURNAL (2014)
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
Sean R. Marcsisin et al.
MALARIA JOURNAL (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Progressing the global antimalarial portfolio:finding drugs which target multiple Plasmodium life stages
Paul W. Smith et al.
PARASITOLOGY (2014)
Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial
Raquel Gonzalez et al.
PLOS MEDICINE (2014)
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects
Ann K. Miller et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
Joerg J. Moehrle et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
Natalie J. Spillman et al.
CELL HOST & MICROBE (2013)
Novel approaches in antimalarial drug discovery
Jana Held et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report
Lorenz von Seidlein et al.
MALARIA JOURNAL (2013)
Designing the next generation of medicines for malaria control and eradication
Jeremy N. Burrows et al.
MALARIA JOURNAL (2013)
Antimalarial drug discovery - approaches and progress towards new medicines
Erika L. Flannery et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
Jason W. Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Inadequate Efficacy of a New Formulation of Fosmidomycin-Clindamycin Combination in Mozambican Children Less than Three Years Old with Uncomplicated Plasmodium falciparum Malaria
Miguel Lanaspa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections
Christian Supan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Spiroindolone Drug Candidate NITD609 Potently Inhibits Gametocytogenesis and Blocks Plasmodium falciparum Transmission to Anopheles Mosquito Vector
J. C. van Pelt-Koops et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate
S. Wein et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial
Neena Valecha et al.
CLINICAL INFECTIOUS DISEASES (2012)
Whole-cell in vitro screening for gametocytocidal compounds
Leonardo Lucantoni et al.
FUTURE MEDICINAL CHEMISTRY (2012)
The antimalarial pipeline - An update
Florian C. Schrader et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
Advait Nagle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The global pipeline of new medicines for the control and elimination of malaria
Melinda P. Anthony et al.
MALARIA JOURNAL (2012)
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
Emily R. Derbyshire et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Low Anticoagulant Heparin Disrupts Plasmodium falciparum Rosettes in Fresh Clinical Isolates
Anna M. Leitgeb et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
Tao Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Jose M. Coteron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
Ghyslain Mombo-Ngoma et al.
MALARIA JOURNAL (2011)
Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)
Geoffrey S. Dow et al.
MALARIA JOURNAL (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Stephan Meister et al.
SCIENCE (2011)
Randomized, Double-Blind Study of the Safety, Tolerability, and Efficacy of Tafenoquine versus Mefloquine for Malaria Prophylaxis in Nonimmune Subjects
Peter E. Nasveld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Arterolane, a New Synthetic Trioxolane for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Phase II, Multicenter, Randomized, Dose-Finding Clinical Trial
Neena Valecha et al.
CLINICAL INFECTIOUS DISEASES (2010)
In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon
Jana Held et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Artemisinin combination therapy for vivax malaria
Nicholas M. Douglas et al.
LANCET INFECTIOUS DISEASES (2010)
Thousands of chemical starting points for antimalarial lead identification
Francisco-Javier Gamo et al.
NATURE (2010)
Chemical genetics of Plasmodium falciparum
W. Armand Guiguemde et al.
NATURE (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso
Mamadou Bountogo et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
Evaluation of Artemisone Combinations in Aotus Monkeys Infected with Plasmodium falciparum
Nicanor Obaldia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Progress in the development of piperaquine combinations for the treatment of malaria
Umberto D'Alessandro
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
High absolute bioavailability of methylene blue given as an aqueous oral formulation
Ingeborg Walter-Sack et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
Boubacar Coulibaly et al.
PLOS ONE (2009)
Pharmacokinetic and Toxicological Profile of Artemisinin Compounds: An Update
Bikash Medhi et al.
PHARMACOLOGY (2009)
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone
Johannes Nagelschmitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum
Margaret A. Phillips et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria
Ronnatrai Ruangweerayut et al.
MALARIA JOURNAL (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and Efficacy of Methylene Blue Combined with Artesunate or Amodiaquine for Uncomplicated Falciparum Malaria: A Randomized Controlled Trial from Burkina Faso
Augustin Zoungrana et al.
PLOS ONE (2008)
The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific
N. J. Elmes et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Understanding artemisinin-induced brainstem neurotoxicity
Raymond F. Genovese et al.
ARCHIVES OF TOXICOLOGY (2008)
Cardiotoxicity of antimalarial drugs
Nicholas J. White
LANCET INFECTIOUS DISEASES (2007)
Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria
Kesara Na-Bangchang et al.
MALARIA JOURNAL (2007)
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria
Sunny Oyakhirome et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Tafenoquine: a promising new antimalarial agent
Maryanne Crockett et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo
L. Vivas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Methylene blue for malaria in Africa:: results from a dose-finding study in combination with chloroquine
Peter E. Meissner et al.
MALARIA JOURNAL (2006)
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria
Steffen Borrmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from gabon
A Kreidenweiss et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841] -: art. no. 45
PE Meissner et al.
MALARIA JOURNAL (2005)
Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3
O Nicolas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria
S Borrmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase
J Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mono- and bis-thiazolium salts have potent antimalarial activity
A Hamzé et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Fosmidomycin-clindamycin for plasmodium falciparum infections in African children
S Borrmann et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Identification of an antimalarial synthetic trioxolane drug development candidate
JL Vennerstrom et al.
NATURE (2004)
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria
J Rengelshausen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Primaquine therapy for malaria
JK Baird et al.
CLINICAL INFECTIOUS DISEASES (2004)
Prodrugs of bisthiazolium salts are orally potent antimalarials
HJ Vial et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse
DS Walsh et al.
CLINICAL INFECTIOUS DISEASES (2004)
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P-falciparum malaria
DS Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Heme binding contributes to antimalarial activity of bis-quaternary ammoniums
GA Biagini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum
BR Hale et al.
CLINICAL INFECTIOUS DISEASES (2003)
Fosmidomycin, a novel chemotherapeutic agent for malaria
B Lell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria) in Australian Defence Force personnel
P Nasveld et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2002)
Clindamycin as an antimalarial drug: Review of clinical trials
B Lell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria
GD Shanks et al.
CLINICAL INFECTIOUS DISEASES (2001)
In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites
L Delhaes et al.
PARASITOLOGY RESEARCH (2001)
Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site
M Korsinczky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Malaria chemoprophylaxis with tafenoquine: a randomised study
B Lell et al.
LANCET (2000)
分享论文
